Messam CA - Search Results

1

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study.

Winer ES, Safran H, Karaszewska B, Richards DA, Hartner L, Forget F, Ramlau R, Kumar K, Mayer B, Johnson BM, Messam CA, Mostafa Kamel Y. Winer ES, et al. Among authors: messam ca. Cancer Med. 2015 Jan;4(1):16-26. doi: 10.1002/cam4.326. Epub 2014 Aug 28. Cancer Med. 2015. PMID: 25165041 Free PMC article. Clinical Trial.

2

A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.

Kellum A, Jagiello-Gruszfeld A, Bondarenko IN, Patwardhan R, Messam C, Mostafa Kamel Y. Kellum A, et al. Curr Med Res Opin. 2010 Oct;26(10):2339-46. doi: 10.1185/03007995.2010.510051. Curr Med Res Opin. 2010. PMID: 20735290 Clinical Trial.

3

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.

Chawla SP, Staddon A, Hendifar A, Messam CA, Patwardhan R, Kamel YM. Chawla SP, et al. Among authors: messam ca. BMC Cancer. 2013 Mar 16;13:121. doi: 10.1186/1471-2407-13-121. BMC Cancer. 2013. PMID: 23497336 Free PMC article. Clinical Trial.

4

Thrombopoietin receptor levels in tumor cell lines and primary tumors.

Erickson-Miller CL, Chadderton A, Gibbard A, Kirchner J, Pillarisetti K, Baker K, Pandite L, El-Hariry I, Mostafa Kamel Y, Liu Y, Martin AM, Messam C. Erickson-Miller CL, et al. J Oncol. 2010;2010:135354. doi: 10.1155/2010/135354. Epub 2010 Dec 28. J Oncol. 2010. PMID: 21318160 Free PMC article.

5

Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.

Erickson-Miller CL, Pillarisetti K, Kirchner J, Figueroa DJ, Ottesen L, Martin AM, Liu Y, Kamel YM, Messam C. Erickson-Miller CL, et al. BMC Cancer. 2012 Sep 11;12:405. doi: 10.1186/1471-2407-12-405. BMC Cancer. 2012. PMID: 22967017 Free PMC article.

6

Functional differentiation of human brain progenitor cells.

Messam CA, Ding S, Haydon PG. Messam CA, et al. Neuron Glia Biol. 2006 Aug;2(3):187-98. doi: 10.1017/S1740925X06000329. Neuron Glia Biol. 2006. PMID: 18634580

7

Murine brain progenitor cells have the ability to differentiate into functional neurons and integrate into the CNS.

Ding S, Messam CA, Li P, Selzer ME, Dichter MA, Haydon PG. Ding S, et al. Among authors: messam ca. Cell Transplant. 2006;15(8-9):699-710. doi: 10.3727/000000006783981468. Cell Transplant. 2006. PMID: 17269441 Free article.

8

Injuring neurons induces neuronal differentiation in a population of hippocampal precursor cells in culture.

Tseng HC, Ruegg SJ, Maronski M, Messam CA, Grinspan JB, Dichter MA. Tseng HC, et al. Among authors: messam ca. Neurobiol Dis. 2006 Apr;22(1):88-97. doi: 10.1016/j.nbd.2005.10.007. Epub 2005 Dec 5. Neurobiol Dis. 2006. PMID: 16330214

9

Nestin is a potential mediator of malignancy in human neuroblastoma cells.

Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA. Thomas SK, et al. Among authors: messam ca. J Biol Chem. 2004 Jul 2;279(27):27994-9. doi: 10.1074/jbc.M312663200. Epub 2004 Apr 26. J Biol Chem. 2004. PMID: 15117961 Free article.

10

Characterization and isolation of promoter-defined nestin-positive cells from the human fetal pancreas.

Humphrey RK, Bucay N, Beattie GM, Lopez A, Messam CA, Cirulli V, Hayek A. Humphrey RK, et al. Among authors: messam ca. Diabetes. 2003 Oct;52(10):2519-25. doi: 10.2337/diabetes.52.10.2519. Diabetes. 2003. PMID: 14514635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters